3Spine has completed the 50th lumbar total joint replacement using its Motus system, which is currently under FDA investigational device exemption, and its 150th real-world evidence lumbar fusion control case, according to a March 30 press release sent to Becker's.
The real-world evidence fusion study is now at full enrollment, allowing all eligible sites to recruit Motus patients, according to the release.
3Spine's lumbar total joint replacement procedure and Motus device is a new technology, replacing the function of the disc and facet joints through a posterior approach. The technique reconstructs the functional spinal unit, like a hip or knee total joint replacement.
3Spine is still recruiting clinical trial patients for the study but is expecting U.S. approval of Motus by 2025.